China National Accord Medicines Past Earnings Performance
Past criteria checks 4/6
China National Accord Medicines has been growing earnings at an average annual rate of 5.8%, while the Healthcare industry saw earnings growing at 3.9% annually. Revenues have been growing at an average rate of 10.2% per year. China National Accord Medicines's return on equity is 9.1%, and it has net margins of 2.1%.
Key information
5.8%
Earnings growth rate
5.8%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 10.2% |
| Return on equity | 9.1% |
| Net Margin | 2.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How China National Accord Medicines makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 75,881 | 1,626 | 6,461 | 31 |
| 31 Dec 23 | 75,477 | 1,599 | 6,480 | 27 |
| 30 Sep 23 | 75,412 | 1,629 | 6,550 | 27 |
| 30 Jun 23 | 75,702 | 1,643 | 6,554 | 21 |
| 31 Mar 23 | 74,979 | 1,597 | 6,476 | 11 |
| 31 Dec 22 | 73,443 | 1,487 | 6,396 | 9 |
| 30 Sep 22 | 72,765 | 1,310 | 6,121 | 0 |
| 30 Jun 22 | 71,324 | 1,269 | 6,024 | 0 |
| 31 Mar 22 | 69,459 | 1,260 | 5,974 | 0 |
| 31 Dec 21 | 68,358 | 1,336 | 5,816 | 0 |
| 30 Sep 21 | 66,979 | 1,478 | 5,758 | 0 |
| 30 Jun 21 | 65,643 | 1,500 | 5,582 | 0 |
| 31 Mar 21 | 62,875 | 1,482 | 5,205 | 0 |
| 31 Dec 20 | 59,649 | 1,402 | 4,946 | 0 |
| 30 Sep 20 | 56,244 | 1,306 | 4,536 | 0 |
| 30 Jun 20 | 54,358 | 1,262 | 4,268 | 0 |
| 31 Mar 20 | 53,539 | 1,217 | 4,164 | 0 |
| 31 Dec 19 | 52,787 | 1,268 | 4,020 | 0 |
| 30 Sep 19 | 50,779 | 1,243 | 3,981 | 0 |
| 30 Jun 19 | 47,943 | 1,218 | 3,837 | 0 |
| 31 Mar 19 | 44,937 | 1,217 | 3,681 | 0 |
| 31 Dec 18 | 43,122 | 1,211 | 3,525 | 0 |
| 30 Sep 18 | 41,751 | 1,182 | 3,316 | 0 |
| 30 Jun 18 | 41,517 | 1,143 | 3,205 | 0 |
| 31 Mar 18 | 41,298 | 1,078 | 3,087 | 0 |
| 31 Dec 17 | 41,263 | 1,058 | 3,030 | 0 |
| 30 Sep 17 | 41,418 | 1,080 | 2,973 | 0 |
| 30 Jun 17 | 41,211 | 1,084 | 2,993 | 0 |
| 31 Mar 17 | 41,159 | 1,205 | 2,979 | 0 |
| 31 Dec 16 | 41,248 | 1,187 | 3,027 | 0 |
| 30 Sep 16 | 49,249 | 1,263 | 4,452 | 0 |
| 30 Jun 16 | 45,568 | 1,199 | 3,926 | 0 |
| 31 Mar 16 | 41,870 | 984 | 3,415 | 0 |
| 31 Dec 15 | 37,819 | 928 | 2,899 | 0 |
| 30 Sep 15 | 25,740 | 721 | 974 | 0 |
| 30 Jun 15 | 25,155 | 693 | 941 | 0 |
| 31 Mar 15 | 24,683 | 682 | 990 | 0 |
| 31 Dec 14 | 23,954 | 652 | 976 | 0 |
| 30 Sep 14 | 23,418 | 629 | 944 | 0 |
| 30 Jun 14 | 22,680 | 607 | 949 | 0 |
| 31 Mar 14 | 21,864 | 545 | 911 | 0 |
| 31 Dec 13 | 21,199 | 520 | 886 | 0 |
| 30 Sep 13 | 20,192 | 515 | 849 | 0 |
| 30 Jun 13 | 19,340 | 497 | 831 | 0 |
Quality Earnings: 000028 has high quality earnings.
Growing Profit Margin: 000028's current net profit margins (2.1%) are higher than last year (2.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 000028's earnings have grown by 5.8% per year over the past 5 years.
Accelerating Growth: 000028's earnings growth over the past year (1.8%) is below its 5-year average (5.8% per year).
Earnings vs Industry: 000028 earnings growth over the past year (1.8%) exceeded the Healthcare industry -1%.
Return on Equity
High ROE: 000028's Return on Equity (9.1%) is considered low.